(Q87641174)
Statements
The role of relative lymphocyte count as a biomarker for the effect of catumaxomab on survival in malignant ascites patients: results from a phase II/III study (English)
Carsten Bokemeyer
Markus M Heiss
Michael A Ströhlein
Simon L Parsons
Diane Seimetz
Horst Lindhofer